Reuters — Specialty chemicals maker DuPont is considering a sale of its nutrition and biosciences unit, Bloomberg reported on Tuesday, citing people familiar with the matter. The unit, which supplies everything from soy-based food ingredients to tablet binders, could be worth at least US$20 billion as a standalone entity, Bloomberg said. DuPont declined to comment
